Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17651713rdf:typepubmed:Citationlld:pubmed
pubmed-article:17651713lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17651713lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:17651713lifeskim:mentionsumls-concept:C0005516lld:lifeskim
pubmed-article:17651713lifeskim:mentionsumls-concept:C0020616lld:lifeskim
pubmed-article:17651713lifeskim:mentionsumls-concept:C0023816lld:lifeskim
pubmed-article:17651713lifeskim:mentionsumls-concept:C0577559lld:lifeskim
pubmed-article:17651713lifeskim:mentionsumls-concept:C0021655lld:lifeskim
pubmed-article:17651713lifeskim:mentionsumls-concept:C0359086lld:lifeskim
pubmed-article:17651713lifeskim:mentionsumls-concept:C1561560lld:lifeskim
pubmed-article:17651713lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:17651713lifeskim:mentionsumls-concept:C1561561lld:lifeskim
pubmed-article:17651713lifeskim:mentionsumls-concept:C1547135lld:lifeskim
pubmed-article:17651713lifeskim:mentionsumls-concept:C1547139lld:lifeskim
pubmed-article:17651713lifeskim:mentionsumls-concept:C0439841lld:lifeskim
pubmed-article:17651713pubmed:issue1-2lld:pubmed
pubmed-article:17651713pubmed:dateCreated2007-8-20lld:pubmed
pubmed-article:17651713pubmed:abstractTextLipoprotein lipase (LPL) is a key enzyme in the metabolism of triglyceride (TG)-rich lipoproteins. LPL in the preheparin serum (Pr-LPL) mass reflects the insulin sensitivity of diabetic patients (DM) receiving neither insulin nor hypoglycemic agents.lld:pubmed
pubmed-article:17651713pubmed:languageenglld:pubmed
pubmed-article:17651713pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17651713pubmed:citationSubsetIMlld:pubmed
pubmed-article:17651713pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17651713pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17651713pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17651713pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17651713pubmed:statusMEDLINElld:pubmed
pubmed-article:17651713pubmed:monthSeplld:pubmed
pubmed-article:17651713pubmed:issn0009-8981lld:pubmed
pubmed-article:17651713pubmed:authorpubmed-author:AizawaYoshifu...lld:pubmed
pubmed-article:17651713pubmed:authorpubmed-author:ObayashiKonen...lld:pubmed
pubmed-article:17651713pubmed:authorpubmed-author:ItoTakakoTlld:pubmed
pubmed-article:17651713pubmed:authorpubmed-author:HirayamaSatos...lld:pubmed
pubmed-article:17651713pubmed:authorpubmed-author:MiidaTakashiTlld:pubmed
pubmed-article:17651713pubmed:authorpubmed-author:HanyuOsamuOlld:pubmed
pubmed-article:17651713pubmed:authorpubmed-author:SodaSatoshiSlld:pubmed
pubmed-article:17651713pubmed:authorpubmed-author:FuekiYurikoYlld:pubmed
pubmed-article:17651713pubmed:authorpubmed-author:KosugeKeiichi...lld:pubmed
pubmed-article:17651713pubmed:authorpubmed-author:WardaningsihE...lld:pubmed
pubmed-article:17651713pubmed:issnTypePrintlld:pubmed
pubmed-article:17651713pubmed:volume384lld:pubmed
pubmed-article:17651713pubmed:ownerNLMlld:pubmed
pubmed-article:17651713pubmed:authorsCompleteYlld:pubmed
pubmed-article:17651713pubmed:pagination118-23lld:pubmed
pubmed-article:17651713pubmed:meshHeadingpubmed-meshheading:17651713...lld:pubmed
pubmed-article:17651713pubmed:meshHeadingpubmed-meshheading:17651713...lld:pubmed
pubmed-article:17651713pubmed:meshHeadingpubmed-meshheading:17651713...lld:pubmed
pubmed-article:17651713pubmed:meshHeadingpubmed-meshheading:17651713...lld:pubmed
pubmed-article:17651713pubmed:meshHeadingpubmed-meshheading:17651713...lld:pubmed
pubmed-article:17651713pubmed:meshHeadingpubmed-meshheading:17651713...lld:pubmed
pubmed-article:17651713pubmed:meshHeadingpubmed-meshheading:17651713...lld:pubmed
pubmed-article:17651713pubmed:meshHeadingpubmed-meshheading:17651713...lld:pubmed
pubmed-article:17651713pubmed:meshHeadingpubmed-meshheading:17651713...lld:pubmed
pubmed-article:17651713pubmed:meshHeadingpubmed-meshheading:17651713...lld:pubmed
pubmed-article:17651713pubmed:meshHeadingpubmed-meshheading:17651713...lld:pubmed
pubmed-article:17651713pubmed:meshHeadingpubmed-meshheading:17651713...lld:pubmed
pubmed-article:17651713pubmed:meshHeadingpubmed-meshheading:17651713...lld:pubmed
pubmed-article:17651713pubmed:year2007lld:pubmed
pubmed-article:17651713pubmed:articleTitlePreheparin lipoprotein lipase mass is a practical marker of insulin resistance in ambulatory type 2 diabetic patients treated with oral hypoglycemic agents.lld:pubmed
pubmed-article:17651713pubmed:affiliationDivision of Endocrinology and Metabolism, Department of Homeostatic Regulation and Development, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi, Niigata 951-8510, Japan.lld:pubmed
pubmed-article:17651713pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17651713pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed